Viz.ai Competitive Intelligence & Landscape

Viz.ai (viz.ai) is a pioneering healthcare technology company that leverages artificial intelligence (AI) to transform patient care and enhance clinical outcomes [https://viz.ai/]. The company specializes in an AI-powered care coordination platform designed to bridge the gaps between patients, clinicians, and critical treatments [https://viz.ai/]. With over 50 advanced, FDA-cleared algorithms, Viz.ai focuses on accelerating disease detection and facilitating intelligent care coordination across various medical specialties [https://viz.ai/].

Viz.ai offers a comprehensive suite of products tailored for different medical needs, including the Viz Neuro Suite for conditions like cerebral aneurysm and large vessel occlusion, the Viz Vascular Suite for aortic disease and pulmonary embolism, and the Viz Cardio Suite for hypertrophic cardiomyopathy and acute coronary syndrome [https://viz.ai/]. Recent expansions include the Viz Pulmonary Suite, a comprehensive AI-powered solution for pulmonary care delivery, and the Viz Oncology Suite [https://viz.ai/, https://www.viz.ai/news/viz-ai-closes-2025-with-record-scale-and-patient-impact]. The platform also includes Viz Assist, a workflow assistant, and Viz One, an enterprise platform for broader healthcare system integration [https://viz.ai/].

The target market for Viz.ai includes healthcare providers, hospitals, and health systems, with its platform actively used across 2,000 hospitals and health systems in the U.S. and Europe [https://www.viz.ai/trust-center]. The company also collaborates with life sciences partners to drive patient care innovation [https://viz.ai/]. Headquartered in San Francisco, CA, Viz.ai Inc. is dedicated to protecting clinical data at scale, operating under rigorous, independently verified security and privacy standards to meet the expectations of leading health systems and regulators [https://www.viz.ai/business-entities, https://www.viz.ai/trust-center]. Their mission is to harness the power of AI to transform healthcare, ensuring better outcomes and accelerating the delivery of life-saving treatments [https://viz.ai/, https://www.viz.ai/our-story].

Viz.ai offers a robust, AI-powered care coordination platform that revolutionizes patient care through its core offering, Viz.ai One. This enterprise platform is driven by over 50 advanced, FDA-cleared algorithms designed to close gaps between patients, clinicians, and life-saving treatments. While specific pricing plans and tiers are not publicly disclosed, the platform's modular design suggests a customizable solution tailored to the needs of different healthcare systems and specialties. Recent developments include the launch of Viz Pulmonary Suite, a comprehensive AI-powered solution dedicated to pulmonary care delivery, expanding the platform's reach into new clinical pathways.

The Viz.ai One platform serves as the central hub for various specialized suites, each addressing specific medical disciplines. These include the Viz Neuro Suite for neurovascular care, the Viz Vascular Suite for aortic disease and pulmonary embolism, the Viz Cardio Suite covering conditions like hypertrophic cardiomyopathy and acute coronary syndrome, and the newly introduced Viz Pulmonary Suite. Each suite leverages AI-powered tools, such as Viz Assist, a workflow assistant that summarizes patient information from EHRs to save time. The company also offers Viz Radiology Suite with AI-powered assist tools for radiologists, Viz Trauma Suite, and Viz Oncology Suite, indicating a broad and evolving product landscape.

While Viz.ai does not publicly list free vs. paid features, the enterprise nature of its solutions, coupled with its focus on complex care coordination and over 50 FDA-cleared AI models, suggests a premium, subscription-based model for healthcare providers and life sciences partners. The company emphasizes its collaboration with Microsoft Cloud for Healthcare to empower radiologists and unify teams, further indicating an integrated, high-value service.

Viz.ai continuously innovates, as evidenced by the launch of Viz Agent Studio, which enables health systems to build and scale their own AI care pathways, highlighting a commitment to expanding customizable AI capabilities for its clients.

Viz.ai demonstrates a consistent commitment to growth and innovation, particularly within the AI-powered healthcare coordination sector. The company actively maintains a careers page [https://www.viz.ai/careers] and a dedicated jobs portal [https://www.viz.ai/jobs], which serve as central hubs for prospective employees. While specific numbers on hiring trends are not publicly detailed, the presence of numerous job openings across various departments signals ongoing expansion and a need for specialized talent in areas like AI development, clinical solutions, and business development.

There is no public information or press releases from Viz.ai indicating any recent layoffs. Instead, their public communications emphasize a positive work environment, with the company having won four Comparably Awards for "Best Place to Work" [https://www.viz.ai/news/viz-ai-wins-four-comparably-awards-for-best-place-to-work]. This suggests a stable employment landscape and a focus on employee satisfaction within the organization, which is often characteristic of growing technology companies.

The hiring patterns at Viz.ai strongly reflect its strategic focus on expanding its AI-powered care coordination platform. Recent product launches, such as the Viz Pulmonary Suite, and discussions around Agentic AI in healthcare, highlight a continued investment in developing new applications and refining existing algorithms. The demand for talent in these advanced technological areas signals the company's ambition to remain a leader in leveraging AI to close care gaps and improve patient outcomes across various medical disciplines, including neurology, cardiology, and pulmonary care [viz.ai/].

Viz.ai has demonstrated robust financial growth and fundraising success, solidifying its position as a leader in AI-powered care coordination. The company successfully raised $71 million in a Series C funding round. This significant investment was co-led by Scale Venture Partners and Insight Partners, with additional participation from notable firms including Greenoaks, Kleiner Perkins, Threshold Ventures, CRV, Innovation Endeavors, and Susa Ventures [https://www.viz.ai/news/viz-ai-raises-71-million-series-c-round-led-by-scale-venture-partners-and-insight-partners]. This funding was earmarked to accelerate Viz.ai's expansion and further its mission of transforming healthcare outcomes through its innovative platform [https://www.viz.ai/news/viz-ai-raises-71-million-series-c-round-led-by-scale-venture-partners-and-insight-partners].

Viz.ai closed 2025 with record scale and patient impact, achieving profitability in its healthcare business. The company's footprint expanded to nearly 2,000 hospitals, and its Life Sciences business doubled over the previous 18 months, driven by six new partnerships with top pharmaceutical companies [https://www.viz.ai/news/viz-ai-closes-2025-with-record-scale-and-patient-impact]. This indicates strong financial health and successful market penetration in both clinical and life sciences sectors.

The company's growth trajectory continued with significant adoption metrics. By January 2024, Viz.ai's platform had been adopted by over 1,500 hospitals nationwide in the United States, encompassing the majority of the 50 largest healthcare systems [https://www.viz.ai/news/viz-ai-adoption-surpasses-1500-hospitals-nationwide]. Its user base also saw substantial growth, increasing by nearly 30% in 2023 to 45,000 healthcare providers. This expansion was fueled by the broadening of its Viz.ai One platform with more use cases, particularly within cardiovascular disease, alongside forming four new strategic partnerships [https://www.viz.ai/news/viz-ai-adoption-surpasses-1500-hospitals-nationwide].

Viz.ai actively participates in a variety of industry events, including major conferences, trade shows, and webinars, to showcase its AI-powered care coordination platform and engage with healthcare professionals. The company maintains a dedicated section on its website to explore both upcoming and past events and webinars [Source: https://www.viz.ai/events]. These platforms are crucial for Viz.ai to highlight advancements like the Viz Pulmonary Suite, a comprehensive AI-powered solution for pulmonary care delivery [Source: https://www.viz.ai/events].

Viz.ai has a consistent presence at prominent medical conferences, demonstrating its commitment to various specialties. For instance, Viz.ai anticipates attending ATS 2026 [Source: https://www.viz.ai/events/ats-2026], ASCO 2026 [Source: https://www.viz.ai/events/asco-2026], ISC 2026 to showcase neurovascular solutions [Source: https://www.viz.ai/events/isc-2026], SIR 2026 [Source: https://www.viz.ai/events/sir-2026], J.P. Morgan Healthcare Conference [Source: https://www.viz.ai/events/jpm-2026], and ASNR 2026 for AI-powered neuro solutions [Source: https://www.viz.ai/events/asnr-2026]. These participations underscore Viz.ai's broad impact across multiple medical disciplines.

In addition to these, Viz.ai was scheduled to be at ACC 2026 in New Orleans, Louisiana, at Booth 219 within the Ernest N. Morial Convention Center. At this event, Viz.ai aimed to demonstrate how its AI-powered care coordination enhances cardiovascular care, including participating in sessions such as “Governance That Works: Constructing Guardrails for Clinical AI in Practice,” which was part of the Artificial Intelligence Intensive Session II: Financing and Governing Augmented Intelligence [Source: https://www.viz.ai/events/acc-2026]. These engagements allow Viz.ai to contribute to critical discussions around AI implementation in healthcare.

Furthermore, Viz.ai regularly hosts and participates in webinars, offering insights into its technology and clinical applications. Topics often include discussions on how to transition from pilot programs to enterprise-scale AI in healthcare, exploring partnerships for transformative change [Source: https://www.viz.ai/webinars]. These online events provide accessible platforms for clinicians and industry stakeholders to learn more about Viz.ai's innovations and thought leadership in the evolving landscape of medical AI.